U.S. Warns Bayer HealthCare AG (JOBS), Amylin Pharmaceuticals, Inc. (JOBS), Cephalon, Inc., Eli Lilly and Company (JOBS) to Stop Using "Misleading" Promotions for Some Drugs

Published: Jan 13, 2010

Bookmark and Share

Reuters -- The U.S. Food and Drug Administration has asked Bayer AG (BAYGn.DE), Amylin Pharmaceuticals (AMLN.O), Eli Lilly (LLY.N) and Cephalon (CEPH.O) to stop using "misleading" promotions for some drugs, according to letters released by the agency on Tuesday.

Back to news